Prospects for the Commercialization of Low-Dose X-ray Image Processing Technology Using AI to Remove Image Noise
DRGEM (CEO J. B. Park), a leading global provider of X-ray solutions, announced that it is driving innovation in the field of fluoroscopy—a technology that uses X-rays to visualize the inside of the human body in real time—by incorporating artificial intelligence (AI) into image processing technology for C-arm equipment.
Known as “PROVUE,” this device analyzes X-ray images acquired at low doses using an AI-based denoising algorithm to remove image noise, thereby significantly reducing radiation exposure for both patients and physicians.
Minimizing X-ray dose during real-time observation of the human body has long been a key technical challenge in fluoroscopy, and achieving high image quality in a low-dose environment remains a technically difficult task. DRGEM explained that it has achieved tangible results by developing AI-powered image processing technology through joint research with KAIST.
In particular, this technology has further improved image noise removal performance by training the AI not only on random noise but also on real noise data generated in actual clinical environments. DRGEM stated that through the AI denoising technology applied to PROVUE, it has confirmed the potential to achieve a similar level of image quality at a radiation dose approximately 70% lower than conventional methods.
DRGEM CEO J. B. Park stated, “PROVUE is a device developed with a dual focus on enhancing the convenience of medical staff and ensuring the safety of both medical staff and patients,” adding, “We plan to continue developing technology to simultaneously improve the usability and image quality of medical imaging equipment in the future.”
DRGEM anticipates that technology development will be completed and the product will enter the market in the second half of 2026.
